Several companies are developing a vaccine for novel influenza A H1N1 virus, and clinical trials of the vaccine are expected to begin soon, according to the national Centers for Disease Control and Prevention (CDC).
At a press briefing June 11, Anne Schuchat, MD, interim deputy director for the CDC's Science and Public Health Program, said that the US government has launched an effort to develop a vaccine against this currently circulating strain, and that the vaccine was expected to be available this fall. In fact, Novartis AG, GlaxoSmithKline PLC, and Baxter International have all announced they have begun the process.
Kuehn BM. H1N1 Vaccine. JAMA. 2009;302(4):375. doi:10.1001/jama.2009.1047